Lucid Diagnostics Inc.
LUCD
$1.16
$0.021.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.13% | 40.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.13% | 40.46% | |||
| Cost of Revenue | 8.57% | 0.77% | |||
| Gross Profit | -21.50% | 44.67% | |||
| SG&A Expenses | 2.83% | -5.93% | |||
| Depreciation & Amortization | 0.00% | 850.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.37% | -5.77% | |||
| Operating Income | -3.29% | 8.83% | |||
| Income Before Tax | -134.22% | 83.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -134.22% | 83.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -134.22% | 83.50% | |||
| EBIT | -3.29% | 8.83% | |||
| EBITDA | -3.38% | 9.00% | |||
| EPS Basic | -20.58% | 84.78% | |||
| Normalized Basic EPS | 5.34% | 36.94% | |||
| EPS Diluted | -20.58% | 84.78% | |||
| Normalized Diluted EPS | 5.34% | 36.94% | |||
| Average Basic Shares Outstanding | 9.28% | 43.89% | |||
| Average Diluted Shares Outstanding | 9.28% | 43.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||